Karyopharm Therapeutics Inc Long-term Investment Intensity

Latest as of September 2021: 0.8%

Karyopharm Therapeutics Inc long-term investment intensity. Karyopharm Therapeutics Inc (KPTI) has a Long-term Investment Intensity of 0.8% as of September 2021. Long-term investments of $2.00 Million represent 0.8% of total assets of $254.09 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read debt load of Karyopharm Therapeutics Inc for a breakdown of total debt and financial obligations.

LT Investment Intensity

0.8%
LT Investments / Total Assets

Long-term Investments

$2.00 Million
USD

Total Assets

$254.09 Million
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Karyopharm Therapeutics Inc (2014–2020)

Long-term investment intensity of Karyopharm Therapeutics Inc from 2014 to 2020. This chart shows how Karyopharm Therapeutics Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2014 to 2020. As of September 2021, the intensity stands at 0.8%, reflecting long-term investments of $2.00 Million against total assets of $254.09 Million USD.

Karyopharm Therapeutics Inc Long-term Investment Intensity by Year (2014–2020)

Karyopharm Therapeutics Inc long-term investment intensity by year from 2014 to 2020. The table below presents the year-by-year Long-term Investment Intensity for Karyopharm Therapeutics Inc from 2014 to 2020, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Karyopharm Therapeutics Inc.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2020 7.7% $24.21 Million $313.05 Million ▲ +7.1 pp
2019 0.7% $2.02 Million $294.96 Million ▲ +0.1 pp
2018 0.6% $2.00 Million $341.19 Million ▼ -15.7 pp
2017 16.3% $29.40 Million $180.29 Million ▼ -8.9 pp
2016 25.2% $45.43 Million $180.38 Million ▲ +9.5 pp
2015 15.7% $33.88 Million $215.44 Million ▲ +11.8 pp
2014 3.9% $8.66 Million $220.34 Million —
pp = percentage points